<p>During the last 30 years, studies have shown self-help to be effective in a number of areas, and to produce equal or close to equal results compared to face-to-face therapy. The Internet can reach a large number of people at a low cost and add the possibility of two-way communication to self-help, thereby offering cost-effective psychological treatments.</p><p>This thesis is based on four studies and aiming to investigate if self-help treatment conducted through Internet can reduce problems with insomnia, stress and headache and reach effect sizes comparable to previous minimal contact treatment studies. Other aims were to investigate cost-effectiveness, and to examine if adding regular telephone contact would reduce drop-out rates. Treatments involved psychological techniques previously proved to be effective for each problem.</p><p>The first study showed a significant decrease in headache severity, and 50% of the participants in the treatment condition showed a clinically significant improvement. In Study II an Internet-based stress management program resulted in significant reductions of perceived stress, anxiety and depression. Improvements were found in both groups, with stronger effects in the self-help treatment group. Study III, a sleep management program, resulted in statistically significant improvements in the treatment group on all main variables, including total sleep time, total wake time in bed, and sleep efficiency. Some improvements were also found in the control group. Follow-up data indicated that improvements were sustained. Study IV did not confirm the hypothesis that the drop-out rates during headache treatment should decrease significantly if adding short and regular telephone contacts.</p><p>Results from this thesis suggest that Internet is a medium well suited for therapy, with effect sizes comparable to face-to-face therapy, that using Internet as a medium for treatment can reduce costs while still maintaining similar results, and that adding a small amount of telephone contact does not decrease attrition.</p>

De nombreux événements cardiovasculaires se déroulent au cours du sommeil(13).Divers auteurs ont étudié la variabilité du rythme cardiaque durant les différentes phases du sommeil chez le sujet sain (2) ou souffrant de diverses pathologies (3,5). Seules quelques publications décrivent le lien entre le sommeil et la variabilité du rythme cardiaque (4). L’interaction entre la variabilité du rythme cardiaque et les spectres de puissance du signal EEG de sommeil peut être étudiée par une analyse de cohérence (12). Cette méthode donne les fonctions de cohérence, de gain et de décalage de phases entre deux signaux à une fréquence déterminée. Les signaux principaux utilisés pour cette analyse de cohérence sont la bande de puissance de haute fréquence (HF) de la variabilité de l’intervalle RR, reflet de l’activité cardiaque vagale (14), et la bande de puissance de fréquence delta du signal EEG, associée au sommeil lent profond (1), à la fréquence du maximum de cross-spectrum entre ces bandes de puissances. Dans le but de mieux comprendre cette interaction, diverses questions se posent : • Existe-t-il, chez l’homme jeune en bonne santé, une interaction entre les spectres de puissance de l’intervalle RR et du signal EEG ? • Quelle bande de fréquence des puissances du signal EEG est la plus liée à la bande de puissance de haute fréquence de la variabilité de l’intervalle RR au cours du sommeil ? • Quel est l’impact du vieillissement sur ce lien ? • Existe-t-il une altération complète (cohérence, gain, décalage de phase) de l’interaction entre la bande de puissance de HF de l’intervalle RR et la bande de puissance de fréquence delta de sommeil chez l’individu souffrant d’un syndrome d’apnées-hypopnées de sommeil (SAHS) modéré ou sévère ? • Y a-t-il une diminution des valeurs de la cohérence et une modification du décalage de phase entre les signaux de puissance des bandes de HF du signal ECG et de la fréquence delta de l’EEG au cours du sommeil de la personne souffrant d’insomnie chronique primaire? • Les valeurs du gain pourraient-elles être les seules à être altérées chez le patient souffrant d’un trouble dépressif majeur (TDM)? Pour répondre à ces questions, plusieurs groupes ont été constitués : 8 adultes jeunes (18-23 ans)(11), 19 hommes d’âge moyen (36-54 ans) vs. 16 adultes jeunes (16-28 ans)(10), 12 patients souffrant d’un SAHS sévère vs. 12 patients souffrant d’un SAHS modéré à sévère vs. 12 hommes contrôles (9), 14 hommes souffrant d’insomnie chronique primaire vs. 12 adultes contrôles (8), 10 hommes souffrant de TDM vs. 10 hommes contrôles(7). Aucun patient ne présente une autre pathologie que celle décrite et tous ont été sevrés d’éventuelles médications psychotropes. De ces analyses, il apparaît que, chez l’homme jeune en bonne santé, de toutes les bandes de puissance du signal EEG de sommeil, les modifications de la bande de puissance delta est la plus liée aux modifications de la bande de puissance de haute fréquence de la variabilité du rythme cardiaque (11); et que le lien entre les modifications observées entre les bandes de puissance delta et HF est stable malgré l’effet du vieillissement observé dans l’architecture du sommeil et le contrôle de l’activité cardiaque (10). Les patients souffrant de SAHS présentent une perte du contrôle du lien entre le sommeil et la variabilité du rythme cardiaque, avant même l’apparition des symptômes cliniques cardiaques (9). Les personnes souffrant d’insomnie chronique primaire montrent une diminution de la force, voire une instabilité, du lien dynamique entre l’activité cérébrale de sommeil et la variabilité du rythme cardiaque(8). Les patients souffrant de trouble dépressif majeur démontrent une diminution de l’efficacité du lien entre les structures impliquées dans le contrôle du sommeil et les centres cardiovasculaires, mais pas de la force de ce lien (7), comme suggéré par les observations d’une neuroplasticité altérée chez les personnes dépressives (6). L’étude de la relation entre l’activité cérébrale et la variabilité du rythme cardiaque au cours du sommeil pourrait donc permettre une meilleure compréhension des processus neuro-cérébraux impliqués dans le développement des maladies cardiovasculaires mais également des pathologies de sommeil et des maladies psychiatriques. Elle pourrait peut-être, à l’aide d’une technique simple comprenant des enregistrements ECG et EEG au cours du sommeil, anticiper l’apparition de maladies graves cardiovasculaires, bien avant les premiers signes de la pathologie et permettre ainsi l’application de mesures préventives plutôt que curatives. Références. 1. Aeschbach D, Borbély AA. All-night dynamics of the human sleep EEG. J Sleep Res 1993; 2:70-81. 2. Bonnet MH, Arand DL. Heart rate variability: sleep stage, time of night, and arousal influences. Electroencephalogr Clin Neurophysiol 1997; 102(5):390-396. 3. Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med. 1998 Sep-Oct;60(5):610-5. 4. Brandenberger G, Viola AU, Ehrhart J, Charloux A, Geny B, Piquard F, Simon C. Age-related changes in cardiac autonomic control during sleep. J Sleep Res. 2003; 12(3):173-80. 5. Dingli K, Assimakopoulos T, Wraith PK, Fietze I, Witt C, Douglas NJ. Spectral oscillations of RR intervals in sleep apnoea/hypopnoea syndrome patients. Eur Respir J. 2003; 22: 943-50. 6. Fossati P, Radtchenko A, Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur Neuropsychopharmacol. 2004; 14 Suppl 5:S503-10. 7. Jurysta F, Kempenaers C; Lancini J; Lanquart JP; van de Borne P; Linkowski P. Altered interaction between cardiac vagal influence and delta sleep EEG suggests an altered neuroplasticity in patients suffering from major depressive disorder. Acta Psych Scand (in press) 8. Jurysta F, Lanquart J, Sputaels V, Dumont M, Migeotte PF, Leistedt S, Linkowski P, van de Borne P. The Impact of Chronic Primary Insomnia on the Heart Rate - EEG Variability Link. Clin. Neurophysiol. 2009; 120(6):1054-60. 9. Jurysta F, Lanquart JP, van de Borne P, Migeotte PF, Dumont M, Degaute JP, Linkowski P. The link between cardiac autonomic activity and sleep delta power is altered in men with sleep apnea-hypopnea syndrome. Am J Physiol Regul Integr Comp Physiol. 2006; 291(4):R1165-71. 10. Jurysta F, van de Borne P, Lanquart JP, Migeotte PF, Degaute JP, Dumont M, Linkowski P. Progressive aging does not alter the interaction between autonomic cardiac activity and delta EEG power. Clin Neurophysiol. 2005; 116(4):871-7. 11. Jurysta F, van de Borne P, Migeotte PF, Dumont M, Lanquart JP, Degaute JP, Linkowski P. A study of the dynamic interactions between sleep EEG and heart rate variability in healthy young men. Clin. Neurophysiol. 2003; 114(11):2146-55. 12. Koopmans LH. The Spectral Analysis of Time Series. Academic Press. New York and London, 1974. 13. Lavery CE, Mittleman MA, Cohen MC, Muller JE, Verrier RL. Nonuniform nighttime distribution of acute cardiac events: a possible effect of sleep states. Circulation. 1997; 96(10):3321-7. 14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-381.

Sleep is a basic need, important to physical and psychological recovery. Insomnia implies sleep-related complaints, such as difficulty falling asleep, difficulty staying asleep, early awakening, or non-restorative sleep (NRS) in an individual who has adequate circumstances and opportunity to sleep.  Insomnia is also related to impairment of daytime functions. The prevalence of reported sleep disturbances varies between 15% and 60% in patients with coronary artery disease (CAD) up to five years after intervention. Disturbed sleep may have a negative impact on self-care capacity and behaviours. Little attention has been given to evaluation of sleep promotion through individualized non-pharmacological interventions among CAD patients. The overall aim of this thesis was to describe the impact of sleep quality and disrupted sleep on health-related quality of life (HRQoL) in patients with stable CAD, in comparison to a population-based group. The objective was also to evaluate an individualized non-pharmacological programme to promote self-care in sleep. Four studies were conducted during seven years, starting in 2001. Patients from six hospitals in the south of Sweden were invited to participate. In addition, an age and gender matched population-based group was randomly selected during the same period as the patients and was used for comparison with the CAD patients in two of the studies. Data was collected through interviews, self-reported questionnaires, a study specific sleep diary and actigraphy registrations. A pretest-posttest control design was used to evaluate whether an individualized non-pharmacological intervention programme could promote self-care in sleep-activity in CAD patients. The results showed a high prevalence of insomniac CAD patients out of whom a large proportion were non-rested insomniacs. This showed that NRS is one of the core symptoms of insomnia. On the other hand there were weak or non-significant gender differences with increasing insomnia severity. Severe insomniac CAD patients displayed a two or threefold higher presleep arousal or anxiety score and were more limited in taking physical exercise than the general population. Generally low sleep efficiency (SE%) was revealed in the studies, particularly among severe non-rested insomniac CAD patients. Among CAD patients, the individualized non-pharmacological programme to promote self-care in sleep-activity indicated improvements in sleep and HRQoL. This thesis elucidates the importance of focusing on the individual’s perception of their sleep-activity and health in their local context and supporting self-care management. Furthermore, it is of importance that nurses set individual goals together with the patient in order to increase self-efficacy to promote HRQoL.

During the last 30 years, studies have shown self-help to be effective in a number of areas, and to produce equal or close to equal results compared to face-to-face therapy. The Internet can reach a large number of people at a low cost and add the possibility of two-way communication to self-help, thereby offering cost-effective psychological treatments. This thesis is based on four studies and aiming to investigate if self-help treatment conducted through Internet can reduce problems with insomnia, stress and headache and reach effect sizes comparable to previous minimal contact treatment studies. Other aims were to investigate cost-effectiveness, and to examine if adding regular telephone contact would reduce drop-out rates. Treatments involved psychological techniques previously proved to be effective for each problem. The first study showed a significant decrease in headache severity, and 50% of the participants in the treatment condition showed a clinically significant improvement. In Study II an Internet-based stress management program resulted in significant reductions of perceived stress, anxiety and depression. Improvements were found in both groups, with stronger effects in the self-help treatment group. Study III, a sleep management program, resulted in statistically significant improvements in the treatment group on all main variables, including total sleep time, total wake time in bed, and sleep efficiency. Some improvements were also found in the control group. Follow-up data indicated that improvements were sustained. Study IV did not confirm the hypothesis that the drop-out rates during headache treatment should decrease significantly if adding short and regular telephone contacts. Results from this thesis suggest that Internet is a medium well suited for therapy, with effect sizes comparable to face-to-face therapy, that using Internet as a medium for treatment can reduce costs while still maintaining similar results, and that adding a small amount of telephone contact does not decrease attrition.

Sömnsvårigheter hos ungdomar är ett växande problem i Sverige men det saknas forskning om behandlingsmetoder för åldersgruppen. Syftet med studien var att testa kognitiv terapi med beteendeexperiment (KT-I) på gymnasieungdomar med primär insomni. Studien genomfördes enligt en Single Subject design med för- och eftermätning. Tre ungdomar i åldern 16-18 genomgick en sju veckor lång behandling efter 1-2 veckors baslinjemätning. Resultatet visade att svårighetsgrad av insomni minskade, att funktionsförmågan dagtid förbättrades och behandlingsmålen uppfylldes i hög grad. Dagliga mätningar visade att förändring av sömnrelaterade symtom och dagtidssymtom varierade mellan deltagarna. Graden av vidmakthållande kognitiva processvariabler minskade. Slutsatser som kan dras är att KT-I är en lovande behandlingsmetod för ungdomar med insomni och att metoden bör testas ytterligare i randomiserade kontrollerade studier. / Sleeping difficulties are an increasing problem in Sweden for youths today, but there is a lack of research on treatments for this age group. The aim of the study was to investigate the effects from Cognitive Therapy with Behavioural Experiments (CT-I) on youths with primary insomnia in upper secondary school. The study was conducted according to a Single-Subject design with pre- and posttests. Three youths between the ages of 16-18 participated in a seven week long treatment, after 1-2 weeks of baseline measures. The results showed that the degree of insomnia decreased, that the ability to function during daytime increased, and that the treatment goals were met to a large extent. Daily measures showed that changes in sleep related symptoms and daytime symptoms varied among the participants. The degree of maintaining cognitive processes decreased. The conclusions that can be drawn are that CT-I is a promising treatment for youths with insomnia and that the method should be tested further in randomized controlled studies.

SammanfattningSömnproblem är vanligt förekommande hälsoproblem i befolkningen. Kognitiv beteendeterapi (KBT) har visats vara en effektiv behandling för personer med insomni men mindre forskning har bedrivits på effekten av KBT i grupp för personer med insomni (KBT-I) och samtidiga depressiva symtom. Studien syftade till att undersöka effekten av KBT-I i grupp med avseende på graden av insomni, depressiva symtom, och samvariationen med transdiagnostiska processer. En single-subject design användes med dagliga skattningar och för-, mellan- och eftermätningar. Resultatet visade att graden av insomni minskade för samtliga deltagare och graden av depressiva symtom minskade för majoriteten. En samvariation mellan sömnrelaterad oro, selektiv uppmärksamhet, och insomni fanns. Det återstår för framtida forskning att undersöka de transdiagnostiska processernas samband med insomni och depressiva symtom närmare. / AbstractSleep disorders are a common health problem in the population. Cognitive behavior therapy for insomnia (CBT-I) have proved to be an effective treatment for people with insomnia, but less research has been conducted on the efficacy of CBT-I in a group of people with insomnia (CBT-I) and comorbid depressive symptoms. The purpose of this study was to investigate the effect of CBT-I in group with respect to insomnia, depressive symptoms, and transdiagnostic processes. A single-subject design was used with daily estimates and pre- between-and posttest measures. The study concluded that the degree of insomnia symtoms decreased for all participants and the degree of depressive symptoms decreased for the majority. A correlation was found between sleep-related worry, selective attention, and insomnia. It remains for future research to investigate transdiagnostic processes associated with insomnia and depressive symptoms further.

While the importance of assessing the occupational consequences of insomnia and other sleep disorders is emphasised in clinical nosologies and research guidelines, there is little consensus on which aspects of occupational performance should be assessed, how such impairment should be measured, and how outcomes should be reported. The research programme described in this thesis aimed to address this issue. Chapter 1 presents a systematic review and methodical critique of studies reporting those aspects of occupational performance most impacted by (or most frequently associated with) insomnia symptoms and degraded sleep quality. Equivocal results, wide variations in reporting conventions, and the overall lack of comparability among studies, strongly indicated the need to develop a standardised metric able to quantify sleep related occupational performance and serve as an assessment and outcome instrument suitable for use in research and clinical settings. Informed by the literature review, Chapters 2-4 describe the development and validation of the Loughborough Occupational Impact of Sleep Scale ( LOISS ), a unidimensional 19 item questionnaire that captures sleep-related occupational impairment across a number of workplace domains over a 4-week reference period. Chapters 5-7 describe LOISS outcomes from: i) surveys in a random population sample; ii) a representative sample of the UK workforce; and iii) a clinical sample of patients with obstructive sleep apnoea (before and after treatment with CPAP). Overall, the scale showed strong internal consistency (Cronbach s alpha range=0.84-0.94) and test-retest reliability (r=0.77, r2=0.59, p<0.001), high levels of criterion validity (significantly discriminating between good and poor sleepers), and proved an effective outcome measure in OSA. From the survey data reported in Chapters 2-7, LOISS score distributions showed no consistent gender difference but did show a significant ageing gradient, with sleep-related occupational impairment declining with increasing age. In conclusion, the work presented here supports the usability, validity and reliability of the LOISS as an assessment and outcome instrument, and also demonstrates the utility of this instrument in exploring the dynamics of sleep-related occupational performance

L’insomnie, une condition fréquemment retrouvée dans la population, se caractérise d’abord par une difficulté à initier ou à maintenir le sommeil et/ou par des éveils précoces le matin ou encore par un sommeil non-réparateur. Lorsqu’elle n’est pas accompagnée par des troubles psychiatriques ou médicaux ou un autre trouble de sommeil et qu’elle perdure plus de 6 mois on parle alors d’insomnie primaire chronique. Selon certains, cette condition serait associée à un état d’hyperéveil caractérisé par une augmentation de l’activité autonome sympathique durant le sommeil et l’éveil. Le baroréflexe est un important mécanisme de contrôle à court terme des fluctuations de la tension artérielle (TA) et de la fréquence cardiaque agissant sur le cœur et les vaisseaux sanguins par l’entremise du système nerveux autonome. On appelle sensibilité baroréceptive (SBR) la capacité du baroréflexe de réagir et de contrôler les fluctuations de TA en modulant le rythme cardiaque. De manière générale, la SBR serait augmentée durant la nuit par rapport à la journée. Aussi, il semblerait que le baroréflexe soit impliqué dans le phénomène de baisse physiologique de la TA pendant la nuit. Or, des données de notre laboratoire ont démontré une augmentation de la TA systolique au cours de la nuit ainsi qu’une atténuation de la baisse nocturne de TA systolique chez des sujets avec insomnie primaire chronique comparé à des témoins bons dormeurs. De plus, il a été démontré que le baroréflexe était altéré de façon précoce dans plusieurs troubles cardiovasculaires et dans l’hypertension artérielle. Or, il semblerait que l’insomnie soit accompagnée d’un risque accru de développement de l’hypertension artérielle. Ces études semblent aller dans le sens d’une altération des mécanismes de régulation de la TA dans l’insomnie. Par ailleurs, une réduction de la SBR serait aussi impliquée dans des états associés à une augmentation de l’activité autonome sympathique. Ainsi, nous nous sommes demandé si le baroréflexe pouvait constituer un des mécanismes de contrôle de la TA qui serait altéré dans l’insomnie et pourrait être impliqué dans l’augmentation de l’activité sympathique qui semble accompagner l’insomnie. Jusqu’à présent, le baroréflexe reste inexploré dans l’insomnie. L’objectif principal de ce mémoire était d’évaluer de façon non-invasive la SBR à l’éveil et en sommeil chez 11 sujets atteints d’insomnie primaire chronique comparé à 11 témoins bons dormeurs. L’évaluation du baroréflexe a été effectuée de façon spontanée par la méthode de l’analyse en séquence et par le calcul du coefficient alpha obtenu par l’analyse spectrale croisée de l’intervalle RR et de la TA systolique. De façon concomitante, les paramètres de la variabilité de l’intervalle RR en sommeil et à l’éveil ont aussi été comparés chez ces mêmes sujets. Aucune différence significative n’a été notée au niveau des index de la SBR entre le groupe d’insomniaques et celui des bons dormeurs, à l’éveil ou en sommeil. Cependant, on observe des valeurs légèrement plus faibles de la SBR chez les insomniaques ayant mal dormi (efficacité de sommeil (ES) < 85%) comparés aux insomniaques ayant bien dormi (ES≥ 85%) à la nuit expérimentale durant l’éveil et en sommeil. Par ailleurs, aucune différence n’a été notée entre le groupe d’insomniaques et celui des bons dormeurs au niveau des paramètres de la variabilité RR considérés (intervalle RR, PNN50, LF et HF en valeurs normalisées). En effet, les insomniaques tout comme les bons dormeurs semblent présenter une variation normale de l’activité autonome en sommeil, telle que représentée par les paramètres de la variabilité RR. Ces résultats préliminaires semblent suggérer que les mécanismes du baroréflexe sont préservés chez les sujets atteints d’insomnie primaire chronique tels que diagnostiqués de manière subjective. Cependant, il est possible qu’une altération des mécanismes du baroréflexe ne se révèle chez les insomniaques que lorsque les critères objectifs d’une mauvaise nuit de sommeil sont présents. / Insomnia, one of the most common sleep complaint in the general population, is characterised firstly by a difficulty initiating or maintaining sleep and/or early awakenings or non-restorative sleep. Insomnia is defined as primary when not principally due to another medical or psychiatric condition or other sleep disorder, whereas a minimum of 6 months duration is required to define chronic insomnia. Some authors have hypothesized that insomnia is associated with a state of hyperarousal characterized by increased sympathetic activity during sleep and wakefulness. The arterial baroreflex is an important mechanism providing continuous short term regulation of heart rate and blood pressure (BP) by means of the autonomic nervous system influences over the pacemaker and the peripheral circulation. Baroreflex sensitivity (BRS) is the baroreflex’s capacity to react and control BP changes by adjusting the heart rate. BRS is known to be heightened during the night compared to daytime. Also, it seems that the baroreflex could be involved in the physiological day-to-night BP fall. Previous data from our laboratory demonstrated in subjects with chronic primary insomnia, higher night-time systolic BP and a significant attenuation of the physiologic day-to-night systolic BP fall compared to good sleepers. Besides, the baroreflex has been shown to be altered early in several cardiovascular diseases and to precede hypertension. Subjects with insomnia have been shown to have a higher likelihood to develop daytime hypertension. All of these findings point in the direction of altered BP regulatory mechanisms in insomnia. Furthermore, a reduction of BRS could be implicated in states where higher sympathetic autonomic activity is observed. We hypothesised that the baroreflex could be one of the BP control mechanisms which are altered in insomnia and could be involved in the heightened sympathetic activity observed in insomnia. To our knowledge, the baroreflex has never been investigated previously in insomnia. The primary goal of this study was to investigate non-invasively BRS during wakefulness and sleep in 11 subjects with chronic primary insomnia compared to 11 good sleepers. Baroreflex was investigated spontaneously by the sequence method and by the calculation of the alpha coefficient obtained by cross spectral analysis of RR interval and systolic BP. Simultaneously, RR interval variability components were also compared during wakefulness and sleep between the two groups. No significant differences were found for indices of BRS between insomniacs and good sleepers during wakefulness and sleep. However, slightly lower values of BRS during wakefulness and sleep were noted in insomniacs with poor sleep (sleep efficiency (SE) <85%) versus those with good sleep (SE≥ 85%) at the experimental night. As a secondary finding, no differences were found between the insomniacs and the good sleepers for any of the RR variability components considered (RR interval, PNN50, LF and HF in their normalized units). Indeed, insomniacs like good sleepers exhibited normal variation of autonomic activity during sleep as depicted by the RR variability components. Our preliminary results suggest that baroreflex mechanisms are preserved in subjects with a subjective complaint of chronic primary insomnia. Nevertheless, certain impairment may occur in insomniacs as a function of objective measures of poor sleep.

研究目的 對於慢性腎臟病患者而言，睡眠困擾是十分常見的問題。過去相關研究中，研究對象較偏重於已進入透析治療的患者，且大多著重於探討人口學及臨床變項，而忽略了心理及行為因素（例如睡前激發狀態、睡眠衛生行為）的影響。本研究試圖改善過去研究之不足，釐清心理及行為因子在慢性腎臟病患者的睡眠問題中所扮演之角色。 研究方法 本研究採橫斷性調查研究，於腎臟科門診及血液透析室招募第三期到第五期（eGFR＜60 ml/min/1.73m2）的慢性腎臟病患者。最終納入分析的個案共有152人，其中77人為未達尿毒症的慢性腎臟病患者，75人為穩定接受血液透析治療（3個月以上）的尿毒症患者。受試者需完成匹茲堡睡眠品質量表、失眠嚴重度量表、睡眠衛生行為量表、睡前激發狀態量表、醫院焦慮與憂鬱量表，並且回答和不寧腿症候群、疼痛及皮膚癢程度相關的問題，此外，本研究亦從病歷紀錄中抄錄相關的檢驗數値以及共病情形。 研究結果 未透析患者約有29.9%睡眠品質不佳、23.4%有失眠問題；而血液透析患者約有57.3%睡眠品質不佳、28.0%有失眠的問題。血液透析患者和未透析患者相比，其睡眠品質顯著較差，且失眠較為嚴重。迴歸分析結果顯示，MMSE得分較低、共病較多、疼痛程度較高、和焦慮相關行為較多可預測較差的睡眠品質，而焦慮與憂鬱情緒較高、焦慮相關行為較多、和認知激發程度較高可預測較嚴重的失眠。未透析患者的睡眠問題主要是受到和激發相關的行為或認知活動的影響，而血液透析患者的睡眠則較容易受到疾病和症狀相關因素的影響。 結論 疾病與臨床因素、身體症狀、以及睡眠心理及行為相關因素對於慢性腎臟病患者的睡眠有所影響，但對於未透析和已透析的患者，其影響因素和影響程度可能不同。

Fatigue is common in the general population, and is the hallmark of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Although the occurrence of sleep difficulties is known to be common in subjects with fatigue, research on insomnia in such subjects is absent. The current study sought to examine the impact comorbid insomnia has on level of fatigue in subjects with chronic fatigue. The aim of this study is to assess the relationship between insomnia and chronic fatigue, and examine if the relationship is affected by the endocrine activity in the HPA axis. The following hypotheses were tested: 1) Do patients with chronic fatigue and comorbid insomnia experience more fatigue than patients with chronic fatigue without comorbid insomnia? 2) Do patients with chronic fatigue and with initially comorbid insomnia experience more fatigue after treatment than chronic fatigue patients without comorbid insomnia? 3) Do patients with chronic fatigue who experience improvement in insomnia after treatment also experience less fatigue by the end of treatment compared with patients who do not experience improvement in insomnia? 4) Is the potential relationship between insomnia and chronic fatigue influenced by the activity of the HPA axis as expressed by variation in cortisol output measured by Trier Social Stress Test for Groups (TSST-G)? The study sample consisted of 75 patients with chronic fatigue. Thirty-three met criteria for insomnia, while 42 did not. While staying at Hysnes Rehabilitation Center in Trondheim, Norway, they received a work-related Acceptance and Commitment Therapy (ACT) treatment intervention lasting 3.5 weeks. In addition, they participated in a standardized stress test (Trier Social Stress Test) pre- and post-treatment. Saliva cortisol samples were collected during the test in order to measure variation in cortisol output. The current finding is the first description of how insomnia in patients with chronic fatigue is associated with higher levels of fatigue (p &lt; .05). Further, this study gives preliminary support indicating that remission of insomnia in patients with chronic fatigue can significantly reduce levels of fatigue (p &lt; .05), and furthermore improve the physiological stress-response (p &lt; .05). These results might encourage clinicians to assess and provide specific treatment for insomnia in patients with chronic fatigue as this might improve their treatment results. An aim for further research should be to investigate the effect of specified treatment for insomnia in patients with chronic fatigue.